STAT News

STAT+: A possible comeback for a failed sickle cell gene therapy

Three years ago, a trial for a sickle cell gene-editing therapy a decade in the making ended abruptly after the first patient suffered a serious adverse event. Now, the therapy…

By STAT News

1 min read
STAT+: A possible comeback for a failed sickle cell gene therapy
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights